I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kang, Yuening
24
results:
Search for persons
X
Format
Online (24)
Mediatypes
Articles (Online) (10)
Bookchapter (Online) (2)
OpenAccess-fulltext (12)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety of Iguratimod as an add-on therapy for ..:
Yan, Qingran
;
Zhang, Mei
;
Du, Fang
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
2
Omics-based integrated analysis identified IKZF2 as a bioma..:
Zhou, Mi
;
Kang, Yuening
;
Li, Jun
..
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
3
Comparison of iguratimod and conventional cyclophosphamide ..:
Yan, Qingran
;
Du, Fang
;
Kang, Yuening
...
Trials. 22 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
4
The Role of Pentraxin 3 in Aspergillosis: Reality and Prosp..:
Kang, Yuening
;
Yu, Yuetian
;
Lu, Liangjing
Mycobiology. 48 (2020) 1 - p. 1-8 , 2020
Link:
https://doi.org/10.1080/..
?
5
Iguratimod as an alternative induction therapy for refracto..:
Kang, Yuening
;
Yan, Qingran
;
Fu, Qiong
...
Arthritis Research & Therapy. 22 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
6
Efficacy and safety of Iguratimod as an add-on therapy for ..:
Yan, Qingran
;
Zhang, Mei
;
Du, Fang
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030952/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Omics-based integrated analysis identified IKZF2 as a bioma..:
Zhou, Mi
;
Kang, Yuening
;
Li, Jun
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187727/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
Comparison of iguratimod and conventional cyclophosphamide ..:
Yan, Qingran
;
Du, Fang
;
Kang, Yuening
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356213/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Iguratimod as an alternative induction therapy for refracto..:
Kang, Yuening
;
Yan, Qingran
;
Fu, Qiong
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106733/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
10
Efficacy and safety of Iguratimod as an add-on therapy for ..:
Qingran Yan
;
Mei Zhang
;
Fang Du
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1062919/full. , 2023
Link:
https://doi.org/10.3389/..
?
11
Image_1_Efficacy and safety of Iguratimod as an add-on ther..:
Qingran Yan
;
Mei Zhang
;
Fang Du
...
doi:10.3389/fimmu.2023.1062919.s001. , 2023
Link:
https://doi.org/10.3389/..
?
12
Omics-based integrated analysis identified IKZF2 as a bioma..:
Mi Zhou
;
Yuening Kang
;
Jun Li
..
https://doi.org/10.1038/s41598-022-13336-5. , 2022
Link:
https://doi.org/10.1038/..
?
13
Comparison of iguratimod and conventional cyclophosphamide ..:
Qingran Yan
;
Fang Du
;
Yuening Kang
...
https://doi.org/10.1186/s13063-021-05475-3. , 2021
Link:
https://doi.org/10.1186/..
?
14
Iguratimod as an alternative induction therapy for refracto..:
Yuening Kang
;
Qingran Yan
;
Qiong Fu
...
http://link.springer.com/article/10.1186/s13075-020-02154-7. , 2020
Link:
https://doi.org/10.1186/..
?
15
The Role of Pentraxin 3 in Aspergillosis: Reality and Prosp..:
Yuening Kang
;
Yuetian Yu
;
Liangjing Lu
http://dx.doi.org/10.1080/12298093.2020.1722576. , 2020
Link:
https://doi.org/10.1080/..
1-15
